LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 84 filers reported holding LEAP THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,641 | -24.5% | 13,650 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $6,143 | -48.8% | 13,650 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $12,000 | -25.0% | 13,650 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $16,000 | -33.3% | 13,650 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $24,000 | -45.5% | 13,650 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $44,000 | – | 13,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 900,733 | $1,883,000 | 1.44% |
| Sio Capital Management, LLC | 1,501,998 | $3,139,000 | 0.92% |
| CVI Holdings, LLC | 704,900 | $1,473,000 | 0.55% |
| Perceptive Advisors | 8,476,496 | $17,466,000 | 0.28% |
| Artal Group S.A. | 2,974,000 | $6,216,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 880,000 | $1,839,000 | 0.17% |
| DAFNA Capital Management LLC | 275,000 | $575,000 | 0.17% |
| J. Goldman & Co LP | 1,018,285 | $2,128,000 | 0.13% |
| MYDA Advisors LLC | 100,000 | $209,000 | 0.13% |
| 683 Capital Management, LLC | 526,466 | $1,100,000 | 0.09% |